Skip to main content

Table 2 Patient characteristics associated with LST limitations

From: Limitation of life-sustaining therapies in critically ill patients with COVID-19: a descriptive epidemiological investigation from the COVID-ICU study

Factor

Crude odds ratio (95% confidence interval)

Adjusted odds ratio (95% confidence interval)

P value

Age (years)

  

 < 0.001

 [16–65)

 

 [65–75)

2.50 (1.93 to 3.23)

2.00 (1.51 to 2.65)

 < 0.001

 [75–91]

10.19 (7.64 to 13.59)

8.28 (5.94 to 11.54)

 < 0.001

Female

1.07 (0.85 to 1.35)

0.91 (0.69 to 1.20)

0.507

Nursing home resident

3.86 (2.11 to 7.06)

1.41 (0.65 to 3.07)]

0.381

Clinical frailty scale score

  

 < 0.001

 [1–3]

 

 (3–4]

3.28 (2.42 to 4.45)

1.61 (1.11 to 2.32)

0.012

 (4–10]

6.21 (4.27 to 9.03)

3.03 (1.89 to 4.83)

 < 0.001

Body mass index ≥ 30 kg/m−2

0.88 (0.71 to 1.09)

0.92 (0.71 to 1.19)

0.529

Hypertension

1.81 (1.47 to 2.23)

1.06 (0.82 to 1.37)

0.647

Diabetes

1.64 (1.32 to 2.04)

1.39 (1.06 to 1.81)

0.016

Coronary artery disease

2.59 (1.96 to 3.41)

1.31 (0.93 to 1.85)

0.119

Chronic heart failure

4.25 (2.85 to 6.33)

1.80 (1.11 to 2.91)

0.016

Chronic respiratory disease

1.65 (1.31 to 2.09)

1.26 (0.95 to 1.65)

0.105

Immunodeficiency

1.61 (1.13 to 2.30)

1.44 (0.95 to 2.19)

0.086

Chronic renal failure

  

0.573

 None

 

 Yes w/o dialysis

2.32 (1.65 to 3.24)

1.13 (0.74 to 1.73)

0.578

 Chronic dialysis

2.21 (1.27 to 3.86)

1.43 (0.72 to 2.86)

0.311

Hematological malignancy

1.99 (1.32 to 3.01)

1.77 (1.09 to 2.88)

0.020

Period of admission

  

0.106

 Before March 15, 2020

 

 March 16 to 31, 2020

0.51 (0.35 to 0.73)

0.73 (0.47 to 1.14)

0.164

 April 1 to 15, 2020

0.36 (0.24 to 0.55)

0.55 (0.33 to 0.92)

0.021

 After April 16, 2020

0.47 (0.26 to 0.83)

0.58 (0.29 to 1.13)

0.110

Time since 1st symptom

  

0.003

 < 4 days

 

 4–7 days

0.78 (0.56 to 1.08)

1.02 (0.70 to 1.50)

0.902

 ≥ 8 days

0.42 (0.30 to 0.58)

0.67 (0.46 to 0.98)

0.041

ICU load (%)

  

0.010

 ≤ 100

 

 (100–150]

0.58 (0.43 to 0.78)

0.70 (0.50 to 0.99)

0.042

 (150–200]

0.47 (0.34 to 0.63)

0.63 (0.44 to 0.91)

0.014

 > 200

0.57 (0.41 to 0.80)

1.14 (0.75 to 1.73)

0.533

First 24-h respiratory failure severity

  

 < 0.001

 Not intubated

 

 Mild ARDS PF (200–600]

1.64 (1.21 to 2.23)

1.89 (1.27 to 2.81)

0.002

 Moderate ARDS PF (100–200]

1.80 (1.37 to 2.37)

2.03 (1.40 to 2.94)

 < 0.001

 Severe ARDS PF (0–100]

3.23 (2.37 to 4.41)

3.61 (2.42 to 5.37)

 < 0.001

SOFA cardiovascular ≥ 3

1.84 (1.49 to 2.27)

1.11 (0.83 to 1.48)

0.499

SOFA renal ≥ 3

1.97 (1.39 to 2.80)

1.39 (0.90 to 2.17)

0.141

  1. LST life-sustaining treatment, ICU intensive care unit, SOFA sequential organ failure assessment, ARDS acute respiratory distress syndrome